BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 27335167)

  • 21. Atorvastatin suppresses aldosterone-induced neonatal rat cardiac fibroblast proliferation by inhibiting ERK1/2 in the genomic pathway.
    Wang Q; Cui W; Zhang HL; Hu HJ; Zhang YN; Liu DM; Liu J
    J Cardiovasc Pharmacol; 2013 Jun; 61(6):520-7. PubMed ID: 23429584
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential behaviors of atrial versus ventricular fibroblasts: a potential role for platelet-derived growth factor in atrial-ventricular remodeling differences.
    Burstein B; Libby E; Calderone A; Nattel S
    Circulation; 2008 Apr; 117(13):1630-41. PubMed ID: 18347210
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevention of Simvastatin-Induced Inhibition of Tendon Cell Proliferation and Cell Cycle Progression by Geranylgeranyl Pyrophosphate.
    Tsai WC; Yu TY; Lin LP; Cheng ML; Chen CL; Pang JH
    Toxicol Sci; 2016 Feb; 149(2):326-34. PubMed ID: 26577051
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Simvastatin attenuates the c-Raf/Erk and calcineurin-NFATc2 pathways via inhibition of Hsp90 activity during the development of heart failure.
    Marunouchi T; Fujita K; Takahashi K; Namiki S; Kyo L; Uchida M; Yano E; Tanonaka K
    J Pharmacol Sci; 2023 Jan; 151(1):17-27. PubMed ID: 36522119
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Simvastatin induces apoptosis by a Rho-dependent mechanism in cultured cardiac fibroblasts and myofibroblasts.
    Copaja M; Venegas D; Aránguiz P; Canales J; Vivar R; Catalán M; Olmedo I; Rodríguez AE; Chiong M; Leyton L; Lavandero S; Díaz-Araya G
    Toxicol Appl Pharmacol; 2011 Aug; 255(1):57-64. PubMed ID: 21651924
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Airway mesenchymal cell death by mevalonate cascade inhibition: integration of autophagy, unfolded protein response and apoptosis focusing on Bcl2 family proteins.
    Ghavami S; Sharma P; Yeganeh B; Ojo OO; Jha A; Mutawe MM; Kashani HH; Los MJ; Klonisch T; Unruh H; Halayko AJ
    Biochim Biophys Acta; 2014 Jul; 1843(7):1259-71. PubMed ID: 24637330
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro myotoxicity of the 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, pravastatin, lovastatin, and simvastatin, using neonatal rat skeletal myocytes.
    Masters BA; Palmoski MJ; Flint OP; Gregg RE; Wang-Iverson D; Durham SK
    Toxicol Appl Pharmacol; 1995 Mar; 131(1):163-74. PubMed ID: 7878672
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Simvastatin inactivates beta1-integrin and extracellular signal-related kinase signaling and inhibits cell proliferation in head and neck squamous cell carcinoma cells.
    Takeda I; Maruya S; Shirasaki T; Mizukami H; Takahata T; Myers JN; Kakehata S; Yagihashi S; Shinkawa H
    Cancer Sci; 2007 Jun; 98(6):890-9. PubMed ID: 17428261
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Simvastatin suppresses tissue factor expression and increases fibrinolytic activity in tumor necrosis factor-alpha-activated human peritoneal mesothelial cells.
    Haslinger B; Kleemann R; Toet KH; Kooistra T
    Kidney Int; 2003 Jun; 63(6):2065-74. PubMed ID: 12753293
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Paradoxical effects of statins on aortic valve myofibroblasts and osteoblasts: implications for end-stage valvular heart disease.
    Wu B; Elmariah S; Kaplan FS; Cheng G; Mohler ER
    Arterioscler Thromb Vasc Biol; 2005 Mar; 25(3):592-7. PubMed ID: 15618546
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of the RhoA/Rho-associated, coiled-coil-containing protein kinase-1 pathway is involved in the therapeutic effects of simvastatin on pulmonary arterial hypertension.
    Liu WH; Xu XH; Luo Q; Zhang HL; Wang Y; Xi QY; Zhao ZH; Liu ZH
    Clin Exp Hypertens; 2018; 40(3):224-230. PubMed ID: 29319354
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Laminar shear stress prevents simvastatin-induced adhesion molecule expression in cytokine activated endothelial cells.
    Rossi J; Rouleau L; Emmott A; Tardif JC; Leask RL
    Eur J Pharmacol; 2010 Dec; 649(1-3):268-76. PubMed ID: 20863785
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of simvastatin on remodeling of the left ventricle and aorta in L-NAME-induced hypertension.
    Simko F; Matuskova J; Luptak I; Krajcirovicova K; Kucharska J; Gvozdjakova A; Babal P; Pechanova O
    Life Sci; 2004 Jan; 74(10):1211-24. PubMed ID: 14697405
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential efficacy of 3-hydroxy-3-methylglutaryl CoA reductase inhibitors on the cell cycle of prostate cancer cells.
    Sivaprasad U; Abbas T; Dutta A
    Mol Cancer Ther; 2006 Sep; 5(9):2310-6. PubMed ID: 16985065
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endothelial Klf2-Foxp1-TGFβ signal mediates the inhibitory effects of simvastatin on maladaptive cardiac remodeling.
    Li H; Wang Y; Liu J; Chen X; Duan Y; Wang X; Shen Y; Kuang Y; Zhuang T; Tomlinson B; Chan P; Yu Z; Cheng Y; Zhang L; Liu Z; Zhang Y; Zhao Z; Zhang Q; Liu J
    Theranostics; 2021; 11(4):1609-1625. PubMed ID: 33408770
    [No Abstract]   [Full Text] [Related]  

  • 36. HMG-CoA reductase inhibition reduces monocyte CC chemokine receptor 2 expression and monocyte chemoattractant protein-1-mediated monocyte recruitment in vivo.
    Han KH; Ryu J; Hong KH; Ko J; Pak YK; Kim JB; Park SW; Kim JJ
    Circulation; 2005 Mar; 111(11):1439-47. PubMed ID: 15781755
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Geraniol and beta-ionone inhibit proliferation, cell cycle progression, and cyclin-dependent kinase 2 activity in MCF-7 breast cancer cells independent of effects on HMG-CoA reductase activity.
    Duncan RE; Lau D; El-Sohemy A; Archer MC
    Biochem Pharmacol; 2004 Nov; 68(9):1739-47. PubMed ID: 15450939
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decreased C-reactive protein-induced resistin production in human monocytes by simvastatin.
    Hu WL; Qiao SB; Li JJ
    Cytokine; 2007 Dec; 40(3):201-6. PubMed ID: 18023360
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Simvastatin suppresses leptin expression in 3T3-L1 adipocytes via activation of the cyclic AMP-PKA pathway induced by inhibition of protein prenylation.
    Maeda T; Horiuchi N
    J Biochem; 2009 Jun; 145(6):771-81. PubMed ID: 19254925
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors interfere with angiogenesis by inhibiting the geranylgeranylation of RhoA.
    Park HJ; Kong D; Iruela-Arispe L; Begley U; Tang D; Galper JB
    Circ Res; 2002 Jul; 91(2):143-50. PubMed ID: 12142347
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.